Recognition and Management of Community-Acquired Acute Kidney Injury in Low-Resource Settings

Date: Thursday, December 02, 2021

Time: 01:00 PM Eastern Standard Time

Dr. Ravindra Mehta, an internationally recognized nephrologist, will discuss a multi-country, International Society of Nephrology (ISN) sponsored study demonstrating that a comprehensive program of point-of-care creatinine/eGFR testing, urine dipstick testing, and protocolized care management can improve the recognition of AKI in low-resource settings, improve clinical outcomes, and reduce the overall costs of treating kidney disease. Dr. Mehta was the lead author and investigator of the study.

Dr. Begos will highlight the utility and accuracy of Nova StatSensor Creatinine/eGFR for kidney function screening in multiple settings.Speakers

Dr. Ravindra Mehta, MD
Professor of Medicine, Division of Nephrology
UCSD Department of Medicine

Dennis Begos, MD, FACS, FACRS
Medical Director, Medical and Scientific Affairs
Nova Biomedical

Register

超急性期脳梗塞診療における 迅速クレアチニン測定器の 有用性について

配信日: 2021年06月24日 (木曜日)  18:00 (日本標準時) 以降はオンデマンドで視聴可能です。

所要時間: 15 分

このウェビナーを視聴する

概要

救急外来に関わる先生方におかれては「搬入患者に対し、CTアンギオやMRアンギオの撮影をしたいが、その前の造影剤腎症発症のリスク評価の時間をもっと短くできないか?」と思った経験がお有りではないでしょうか？

本ウェビナーでは、1.2μlの指先血で、30秒で結果表示する【携帯型迅速クレアチニン測定装置】の導入前後での「病着から血管内治療まで」の時間短縮、中央検査部の分析装置との測定値相関状況、といった気になる研究結果が示されます。

症例紹介一例と「rt-PAと血管内治療について」の簡易解説も含め15分間のウェビナーです。
脳神経内科、脳神経外科はもちろん、緊急造影撮影診断をされる先生方におすすめの内容です。

本セミナーは配信開始後はいつでもオンデマンドでご視聴いただけます。

演者：片山 優希 先生（Dr.KATAYAMA Yuki）
脳神経内科
青梅市立総合病院

ノバ・バイオメディカルのウェビナーをもっと見る

ノバ・バイオメディカルWebページ

Comparing the Accuracy of POC Creatinine/eGFR vs. Measured GFR for Evaluating Kidney Disease

Date: Thursday, July 08, 2021 & July 22, 2021

Time: 01:00 PM Eastern Daylight Time

Chronic kidney disease is rising rapidly in low- and middle-income countries due to limited resources and is associated with high morbidity and mortality. Serum creatinine and estimation of glomerular filtration rate (eGFR) are critical diagnostic tools for kidney disease, yet access to centralized laboratory services remains limited in primary care resource-limited settings. In this webinar, Dr. Currin discusses the results of a large, 670 patient study in a rural South African population evaluating point-of-care (POC) technologies for serum creatinine/eGFR measurement and comparing their performance to a gold standard measurement using iohexol measured GFR (mGFR).

Dr. Begos will share Nova Biomedical’s commitment to a close relationship with researchers, clinicians, and government health agencies to improve care for patients with kidney disease worldwide.

Sean Currin, MD
Department of Chemical Pathology
University of Witwatersrand and National Health Laboratory Service

Dennis Begos, MD, FACS, FACRS
Associate Medical Director, Medical and Scientific Affair
Nova Biomedical

Register